BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 8139033)

  • 1. Expression of the TM protein of Rous sarcoma virus in the absence of SU shows that this domain is capable of oligomerization and intracellular transport.
    Einfeld DA; Hunter E
    J Virol; 1994 Apr; 68(4):2513-20. PubMed ID: 8139033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutational analysis of the oligomer assembly domain in the transmembrane subunit of the Rous sarcoma virus glycoprotein.
    Einfeld DA; Hunter E
    J Virol; 1997 Mar; 71(3):2383-9. PubMed ID: 9032375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutants of the Rous sarcoma virus envelope glycoprotein that lack the transmembrane anchor and cytoplasmic domains: analysis of intracellular transport and assembly into virions.
    Perez LG; Davis GL; Hunter E
    J Virol; 1987 Oct; 61(10):2981-8. PubMed ID: 3041017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amino-terminal deletion mutants of the Rous sarcoma virus glycoprotein do not block signal peptide cleavage but can block intracellular transport.
    Hardwick JM; Shaw KE; Wills JW; Hunter E
    J Cell Biol; 1986 Sep; 103(3):829-38. PubMed ID: 3017996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of cytoplasmic domain length on cell surface expression and syncytium-forming capacity of the simian immunodeficiency virus envelope glycoprotein.
    Spies CP; Compans RW
    Virology; 1994 Aug; 203(1):8-19. PubMed ID: 8030287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A charged amino acid substitution within the transmembrane anchor of the Rous sarcoma virus envelope glycoprotein affects surface expression but not intracellular transport.
    Davis GL; Hunter E
    J Cell Biol; 1987 Sep; 105(3):1191-203. PubMed ID: 2821009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oligomerization of a membrane protein correlates with its retention in the Golgi complex.
    Weisz OA; Swift AM; Machamer CE
    J Cell Biol; 1993 Sep; 122(6):1185-96. PubMed ID: 8397214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutations within the proteolytic cleavage site of the Rous sarcoma virus glycoprotein that block processing to gp85 and gp37.
    Perez LG; Hunter E
    J Virol; 1987 May; 61(5):1609-14. PubMed ID: 3033286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transport and processing of the Rous sarcoma virus Gag protein in the endoplasmic reticulum.
    Krishna NK; Weldon RA; Wills JW
    J Virol; 1996 Mar; 70(3):1570-9. PubMed ID: 8627676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutations of the Rous sarcoma virus env gene that affect the transport and subcellular location of the glycoprotein products.
    Wills JW; Srinivas RV; Hunter E
    J Cell Biol; 1984 Dec; 99(6):2011-23. PubMed ID: 6094591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutations at the C-terminus of the simian immunodeficiency virus envelope glycoprotein affect gp120-gp41 stability on virions.
    Affranchino JL; González SA
    Virology; 2006 Mar; 347(1):217-25. PubMed ID: 16380144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Uncoupled expression of Moloney murine leukemia virus envelope polypeptides SU and TM: a functional analysis of the role of TM domains in viral entry.
    Ragheb JA; Anderson WF
    J Virol; 1994 May; 68(5):3207-19. PubMed ID: 7512161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transport of a lysosomally targeted Rous sarcoma virus envelope glycoprotein involves transient expression on the cell surface.
    Johnston PB; Dong JY; Hunter E
    Virology; 1995 Jan; 206(1):353-61. PubMed ID: 7831790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A single glycosylation site within the receptor-binding domain of the avian sarcoma/leukosis virus glycoprotein is critical for receptor binding.
    Delos SE; Burdick MJ; White JM
    Virology; 2002 Mar; 294(2):354-63. PubMed ID: 12009877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutations within the putative membrane-spanning domain of the simian immunodeficiency virus transmembrane glycoprotein define the minimal requirements for fusion, incorporation, and infectivity.
    West JT; Johnston PB; Dubay SR; Hunter E
    J Virol; 2001 Oct; 75(20):9601-12. PubMed ID: 11559792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutations within the env gene of Mason-Pfizer monkey virus: effects on protein transport and SU-TM association.
    Brody BA; Hunter E
    J Virol; 1992 Jun; 66(6):3466-75. PubMed ID: 1316462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oligomeric structure of a prototype retrovirus glycoprotein.
    Einfeld D; Hunter E
    Proc Natl Acad Sci U S A; 1988 Nov; 85(22):8688-92. PubMed ID: 2847170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Receptor-induced conformational changes in the SU subunit of the avian sarcoma/leukosis virus A envelope protein: implications for fusion activation.
    Delos SE; Godby JA; White JM
    J Virol; 2005 Mar; 79(6):3488-99. PubMed ID: 15731243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The SU and TM envelope protein subunits of bovine leukemia virus are linked by disulfide bonds, both in cells and in virions.
    Johnston ER; Radke K
    J Virol; 2000 Mar; 74(6):2930-5. PubMed ID: 10684314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intracellular transport of rubella virus structural proteins expressed from cloned cDNA.
    Baron MD; Ebel T; Suomalainen M
    J Gen Virol; 1992 May; 73 ( Pt 5)():1073-86. PubMed ID: 1588317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.